Sleep Quality & Psoriatic Arthritis
For people living with psoriatic arthritis (PsA), the comfort of a good night's sleep may feel out of reach for many.
Read more →What's hot
View all perspectives
What's Hot
Ultrasound in PsA
Dr. Arthur Kavanaugh discusses abstract 2206 presented at ACR22 in Philadelphia. Abstract 2206: Understanding Inter-rater Variability in Scoring of Entheseal Lesions: Results from the Diagnostic Ultrasound Enthesitis Tool (DUET) Study
Watch video →
Tapering TNFi in nonradiographic AxSpA
Dr. Peter Nash at ACR22 Convergence in Philadelphia, PA.
Watch video →
Sunday (Day 2): ACR 22 Daily Recap
ACR 2022 Daily Recap for Sunday, November 13th. Panelists: Drs. Robert Chao, Antoni Chan, Bella Mehta, Janet Pope, Yuz Yusof, Cassy Sims, Akhil Sood, Sheila Reyes and Jack Cush.
Watch video →
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
Watch video →
Deucravacitinib in PsA
Dr. Arthur Kavanaugh discusses abstract 1598 at ACR22 Convergence in Philadelphia. Abstract 1598: Safety and Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Psoriatic Arthritis: 52-Week Results from a Randomized Phase 2 Trial
Watch video →
Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial
Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at the ACR22 Convergence meeting in Philadelphia, PA. Abstract 1676: Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
Watch video →
PET CT Imaging to Define Risk of Progression from PSO to PsA
Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence.
Watch video →
ACR22 Daily Recap: Saturday Recap
Panelists: Drs. Jack Cush, Michael Putman, Eric Dein, Patricia Harkins and Rachel Tate.
Watch video →
sheila RHEUMarampa
3 years 1 month ago
Dr Tanner presents the features of AFF👇
It is rare, subtrochanteric in location and often appears w/n 5-10 yrs of BP use.
#ACR22 @RheumNow #acrreview #osteoporosis https://t.co/KbMJ4dXfpj
TheDaoIndex KDAO2011
3 years 1 month ago
P1NP is a useful bone turnover marker that Dr. Tanner checks to monitor #osteoporosis therapy (if insurance covers it) - it is not affected by diurnal variation, food, renal function. #ACR22 @rheumnow #ACRReview
sheila RHEUMarampa
3 years 1 month ago
Here's a nice slide comparing Sjogren's disease and Sarcoidosis:
#ACR22 @RheumNow #acrreview #MedTwitter https://t.co/MQQx3GBl5f
Mike Putman EBRheum
3 years 1 month ago
Abbvie launching another upadacitinib phase 3 trial w/essentially zero preliinary data
I personally love this strategy; I think Phase 2's are an expensive waste of time
Better to go big and answer the question?
COI: I participate in SELECT-GCA
#ACR22 @RheumNow #Vasculitis22 https://t.co/fSs3xt8baA
Dr. John Cush RheumNow
3 years 1 month ago
QD Clinic - When to Worry About Malignancy and Myositis
Which myositis patients should you worry and screen for cancer?
https://t.co/bfT0rYNS45 https://t.co/cf59fdxBuC
Eric Dein ericdeinmd
3 years 1 month ago
Tomorrow at 3 pm at #ACR22!
Join my session on Difficult to treat RA
- How do define it?
- What are the patient and synovial characteristics?
- How do we study it?
@RheumNow https://t.co/43UEJhYvRp
Catherine Sims, MD DrCassySims
3 years 1 month ago
Does #COVID19 #vaccine work in #psoriaticarthritis? @RheumNow #ACR22 Abstract #0389
🤚 HR for infection and hospitalization similar between controls and PsA after 2nd vaccination
🤚#Enbrel (OR 2.39) and #JAKi (OR 9.90) higher risk of infection and hospitalization
TheDaoIndex KDAO2011
3 years 1 month ago
“Expert rheumatologist opinion remains the gold standard!” – Dr. J Scher on diagnosis of #axSpa
I would like to think this quote applies to everything, not just to axSpa (-my own opinion)
#ACRreview #ACR22 @rheumnow https://t.co/zpwQwXA8o2
TheDaoIndex KDAO2011
3 years 1 month ago
Withdrawing IL17i will more likely cause a relapse, but pts will respond when reintroduced -Dr Scher #PsA @rheumnow #acr22 #acrreview https://t.co/FvWVuQGJda
Dr. John Cush RheumNow
3 years 1 month ago
Dr. Sheila Reyes is back and covering #ACR22 as a RheumNow reporter. Follow @RHEUMarampa from real-time conference coverage! https://t.co/MeA2RggI9S
TheDaoIndex KDAO2011
3 years 1 month ago
Sialadenosis is a mimic of #sjogren - it related to fatty infiltration/metabolic syndrome. Correct underlying issue and pts will improve - Dr S McCoy @rheumnow #acrreview #acr22 https://t.co/bZPj1LmERs
Catherine Sims, MD DrCassySims
3 years 1 month ago
Wonderful slide by Dr. Sarah McCoy on #Sjogrens #ACR22 @RheumNow
Broad differential for these patients when they present in clinic:
📍Ask about:
🚬 habits
💊 meds
🍬 🩻history: #diabetes, past radiation exposure
🦠 infection (#HIV, #HCV)
🩸 #vitamin deficiency https://t.co/6Qo23lWBs4
After decades of having little else proven apart from glucocorticosteroids with which to treat polymyalgia rheumatica (PMR), evidence for steroid-sparing options has grown in recent years, and this crescendo is set to continue at ACR Convergence 2022 in Philadelphia, PA.
Dr. John Cush RheumNow
3 years 1 month ago
Mark your calendars! RheumNow Live is back on 3/18-3/19 in Dallas, Texas.
Register now!
https://t.co/xQkdHjEVgS https://t.co/moyJhNHgHk
Poster Hall